The 33rd Global Human Resource Management Conference, Barcelona, 4th – 6th April 2001
In developing a new drug, a pharmaceutical company may invest 500-750mm USD over a seven to ten year development period only to find in clinical trials that the drug is not as
effective as needed to be commercially viable or that another company has already launched a competing drug and will now share the market. Companies who are efficient in taking their new compounds to market as quickly as possible have a business advantage over their competition because first-to-market with an effective treatment quickly converts to market share and profit in the highly competitive, capital intensive pharmaceutical industry. Described in this paper is how cross-functional, project-based management methods were introduced into the clinical trial phase of pharmaceutical new product development at GlaxoWellcome (GW) Germany and its resulting improvement in performance.
Thomas Johns PhD and Thomas Lander MD
Type:Articles
Download File:
Article onPM CarreerDevelopment -Glaxo.pdf
English